Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (HBIO) Revenue
Annual & quarterly revenue history · segment & region breakdown
HBIO · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsHarvard Bioscience, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Harvard Bioscience, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Harvard Bioscience, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Harvard Bioscience, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HBIO revenue · 4 questionsHBIO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Harvard Bioscience, Inc. SEC filings · GAAP · Harvard Bioscience, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026